Difference between revisions of "Team:Freiburg/PR"

Line 10: Line 10:
 
<h5  style="text-align: center"> Public Relations </h5>
 
<h5  style="text-align: center"> Public Relations </h5>
 
<div class="para_center_20"><font color="black">
 
<div class="para_center_20"><font color="black">
During our time in the lab it was easy to forget the outside world. There are a few aspects to keep in mind: What would people with non-scientific background think of using spores to deliver drugs. And what would ulcerative colitis affected patients think of this idea? Could there be any ? How can we achieve or improve the acceptance of our work and our product?
+
During our time in the lab it was easy to forget the outside world. There are a few aspects to keep in mind: What would people with non-scientific background think of using spores to deliver drugs. And what would ulcerative colitis affected patients think of this idea? Could there be any concerns about the safety of spores? How can we achieve or improve the acceptance of our work and our product?
 
And also: Is our product applicable under real world conditions?<br><br>
 
And also: Is our product applicable under real world conditions?<br><br>
 
To respond to all those questions, we’ve had talked to a lot of different medical experts in their field (gastroenterologists, dermatologists and pharmacists). The results of the these interviews was the idea to perform two surveys. One aiming for the general public and the other one addressing ulcerative colitis patients. Read more on the following pages.<br><br>
 
To respond to all those questions, we’ve had talked to a lot of different medical experts in their field (gastroenterologists, dermatologists and pharmacists). The results of the these interviews was the idea to perform two surveys. One aiming for the general public and the other one addressing ulcerative colitis patients. Read more on the following pages.<br><br>

Revision as of 12:10, 11 October 2016

Public Relations
During our time in the lab it was easy to forget the outside world. There are a few aspects to keep in mind: What would people with non-scientific background think of using spores to deliver drugs. And what would ulcerative colitis affected patients think of this idea? Could there be any concerns about the safety of spores? How can we achieve or improve the acceptance of our work and our product? And also: Is our product applicable under real world conditions?

To respond to all those questions, we’ve had talked to a lot of different medical experts in their field (gastroenterologists, dermatologists and pharmacists). The results of the these interviews was the idea to perform two surveys. One aiming for the general public and the other one addressing ulcerative colitis patients. Read more on the following pages.

Exchange and relations are very important in science. Throughout the entire project we’ve stayed in contact with many different iGEM teams. Their feedback and comments were crucial to the success of our own work. The help we’ve received and the help we’ve given ourselves, made us all feel very connected with each other. This is what science is all about. In such a big competition like iGEM it important to remember that every team has to face similar difficulties and that working together can solve a lot of problems.

All these efforts gave us a lot of new ideas and in the end we were able to improve our project in a way that we never could have while working only in the lab with only cloning, western blotting and bacteria on our minds..

Posted by: iGEM Freiburg

Nanocillus - 'cause spore is more!